TNFRSF11B and cancer: PARP2KD cancer cells exhibited higher RANKL expression, but lower osteoprotegerin (OPG) expression, leading to an increased RANKL/OPG ratio (Supplementary Fig. 1n), thus facilitating osteoclast differentiation and bone resorption (Supplementary Fig. 1o).